Immune Checkpoint Inhibitor

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)

Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

Toripalimab Plus FLOT in Locally Advanced Gastric Cancer

Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy

LAG3 Expression in Triple Negative Breast Cancer

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody